Methotrexate Tablet
Product Images NDC 16729-486

2 FDA label images from Accord Healthcare Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 16729-486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methotrexate-01 (Methotrexate 01)

Methotrexate-01 (Methotrexate 01)
Chemical structure of Methotrexate, showing its molecular arrangement with multiple ring systems and functional groups, corresponding to the active ingredient methotrexate.*
FDA Label Image

Principal Display Panel (36 Tablets)

Principal Display Panel (36 Tablets)
Label for Methotrexate Tablets, USP 2.5 mg, manufactured by Intas Pharmaceuticals and labeled by Accord Healthcare Inc. The label indicates 36 tablets per container, with warnings including child resistance and cytotoxic agent caution, and storage instructions at 20°C to 25°C. The label includes National Drug Code 16729-486 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.